<DOC>
	<DOCNO>NCT03077984</DOCNO>
	<brief_summary>This project one multi-center , prospective cohort study , base 1660 case ischemic stroke patient treatment 3 month , 21 month follow-up observation order clarify advantage characteristic integrate treatment traditional Chinese medicine sequela apoplexy ; With formation curative effect , highlight advantage programme comprehensive treatment apoplectic sequela traditional Chinese medicine compound preparation ; To form active medical service mode stroke chronic disease management process , well modality mechanisms evaluation curative effect .</brief_summary>
	<brief_title>Study Clinical Efficacy Chinese Medicine Treatment Sequelae Apoplexy</brief_title>
	<detailed_description>There 7 million stroke patient China , 2 million new case stroke patient year , become national first cause death , approximately 3/4 percent survivor lose ability work due apoplexy admit hospital 41.5 % patient recurrent patient . There legacy somatic dysfunction 80 % patient stroke , The remain 55.4 % patient mental disorder , The northwest region China high incidence `` Stroke Belt '' health care system Northwest China weak , The `` four high one low '' problem become serious northwest , Therefore , clerify advantage characteristics traditional Chinese medicine comprehensive treatment sequela apoplexy . The formation active medical service model mode stroke chronic disease management process , evaluation curative effect mechanism paramount importance . In paper 1660 case ischemic stroke patient integrated traditional Chinese medicine therapy 3 month , And 21-month follow-up observation To identify traditional Chinese medicine comprehensive treatment reduce mortality patient ischemic stroke recurrence rate , improve degree disability limbs stroke effect main symptom sequela .</detailed_description>
	<criteria>Patients accordance criterion diagnosis cerebral infarction . Functional Defects Extremities1≤MRS≤5 . Age 18 75 year old ( include 18 75 ) , No gender limitation . Patients agree participate clinical trial sign informed consent form . Patients stable vital sign two week . Patients cerebral infarction acute phase . Patients cerebral infarction , transient ischemic attack , cerebral hemorrhage cerebral arteritis . Patients AF , tumor , brain trauma , brain parasite disease rheumatic heart disease . Patients bleed severe bleed within 3 month . Patients severe hepatitis , Kidneys , blood metabolic system diseases . Pisabilities viewer NIHSS prescribe law . ( Physical disability blind , deaf , dumb , mental disorder , mental disorder ) . Patients history alcohol drug abuse , reduce possibility make hard Project Group accord researcher ' judgment . Allergic constitution drug sensitivity . Patients clinical trial clinical trial drug 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>